Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma
Cody A. Ramirez, Michelle Becker‐Hapak, Kartik Singhal, David A. Russler‐Germain, Felix E. Frenkel, Erica Kay Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga M. Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, , Todd A. Fehniger
This study identifies high-quality neoantigens in follicular lymphoma patients using WES and RNA-Seq, and initiates a clinical trial of personalized neoantigen vaccines combined with PD-1 blockade.
Blood Advances · May 7, 2024Peer-reviewedGenetic & Genomic Medicine